Abstract
BackgroundInitial reports of biologic therapy (mainly TNF-inhibitor) following B-cell depletion suggest this to be safe and effective 1. Disease which has been refractory to B cell depletion therapy may respond...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
